93 related articles for article (PubMed ID: 24078026)
1. Bayesian estimation of HIV-1 dynamics in vivo.
Ushakova A; Pettersen FO; Mæland A; Lindqvist BH; Kvale D
Math Med Biol; 2015 Mar; 32(1):38-55. PubMed ID: 24078026
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian approach to parameter estimation in HIV dynamical models.
Putter H; Heisterkamp SH; Lange JM; de Wolf F
Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633
[TBL] [Abstract][Full Text] [Related]
3. Random changepoint modelling of HIV immunologic responses.
Ghosh P; Vaida F
Stat Med; 2007 Apr; 26(9):2074-87. PubMed ID: 16969894
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
5. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients.
Grelli S; d'Ettorre G; Lauria F; Montella F; Di Traglia L; Lichtner M; Vullo V; Favalli C; Vella S; Macchi B; Mastino A
J Antimicrob Chemother; 2004 Mar; 53(3):494-500. PubMed ID: 14963063
[TBL] [Abstract][Full Text] [Related]
7. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
Lavielle M; Mentré F
J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):229-49. PubMed ID: 17211713
[TBL] [Abstract][Full Text] [Related]
8. Estimation and prediction with HIV-treatment interruption data.
Adams BM; Banks HT; Davidian M; Rosenberg ES
Bull Math Biol; 2007 Feb; 69(2):563-84. PubMed ID: 17211735
[TBL] [Abstract][Full Text] [Related]
9. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells.
Heffernan JM; Wahl LM
J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200
[TBL] [Abstract][Full Text] [Related]
10. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
11. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
12. Joint modeling of longitudinal data and informative dropout time in the presence of multiple changepoints.
Ghosh P; Ghosh K; Tiwari RC
Stat Med; 2011 Mar; 30(6):611-26. PubMed ID: 21337357
[TBL] [Abstract][Full Text] [Related]
13. Modeling HIV-1 dynamics and fitness in cell culture across scales.
Immonen T; Somersalo E; Calvetti D
Bull Math Biol; 2014 Feb; 76(2):486-514. PubMed ID: 24510727
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
16. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
Lepej SZ; Begovac J; Vince A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
18. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
Kousignian I; Autran B; Chouquet C; Calvez V; Gomard E; Katlama C; Rivière Y; Costagliola D;
Stat Med; 2003 May; 22(10):1675-90. PubMed ID: 12720304
[TBL] [Abstract][Full Text] [Related]
19. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
Almeida M; Cordero M; Almeida J; Orfao A
Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
[TBL] [Abstract][Full Text] [Related]
20. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
